Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
In recent years, there has been a growing interest in the field of novel theranostics, which encompasses both Positron emission tomography (PET) imaging and radionuclide therapy. Theranostics aims to integrate diagnostic and therapeutic approaches to personalize patient care. PET imaging plays a crucial role in the diagnostics by enabling the visualization and characterization of specific biological targets and pathways relevant to disease pathology. Moreover, PET allows for the evaluation of novel radiotracers designed to target these biological markers, facilitating the development and optimization of targeted therapies.
This collection seeks submissions of original research from researchers and clinicians actively involved in applying PET imaging techniques with novel biological targets and radiotracers, as well as from scientists working on the development of new radiotracers for PET.